The connection between Telmatosaurus transsylvanicus and oncology is not merely theoretical. A separate, previous study had already identified physical evidence of a tumor in a specimen of this same species. This earlier finding confirmed that cancer is not a modern phenomenon, nor is it exclusive to mammals. Instead, it is a condition with deep evolutionary roots, affecting complex organisms throughout the history of life on Earth. The presence of cancer in a dinosaur from the Hateg Basin provides a specific case study for how these ancient reptiles managed the biological burden of the disease.
Senior author Justin Stebbing, a Professor of Biomedical Sciences at Anglia Ruskin University and a leading expert in oncology, emphasizes the unique value that dinosaurs offer to medical science. "Dinosaurs, as long-lived, large-bodied organisms, present a compelling case for investigating how species managed cancer susceptibility and resistance over millions of years," Professor Stebbing noted. He explains that the sheer size and longevity of many dinosaur species should, in theory, have made them highly susceptible to cancer, as they possessed more cells and lived long enough for mutations to accumulate. Understanding why some survived or how their bodies reacted to these growths could provide clues to natural resistance mechanisms.
The shift toward protein analysis is a strategic move in this field of research. While the quest for ancient DNA often captures the public imagination, proteins offer a more practical and stable medium for scientific inquiry. "Proteins, particularly those found in calcified tissues like bone, are more stable than DNA and are less susceptible to degradation and contamination," Professor Stebbing said. "This makes them ideal candidates for studying ancient diseases, including cancer, in paleontological specimens."
The stability of these proteins means that they can act as biological "time capsules." While a skeleton can tell a researcher about the size, shape, and movement of an animal, it is the soft tissue and the proteins within that provide the molecular narrative. "Unlike skeletal structures alone, soft tissues contain proteins that provide molecular information that can reveal the underlying biological mechanisms of disease," Stebbing added. This molecular information is what allows scientists to move beyond simple observation and into the realm of functional biology, comparing the ancient manifestations of disease with those seen in modern pathology labs.
The implications of this research extend beyond the laboratory and into the field. The study’s authors are calling for a fundamental shift in how fossils are collected and preserved. Traditionally, the focus of paleontological excavations has been on the recovery of complete or impressive skeletal remains for display and structural study. However, this new research highlights the necessity of prioritizing the collection and preservation of fossilized soft tissue. As molecular techniques continue to advance, the value of these seemingly "messy" or non-skeletal remnants will only increase.
